Hareklea Markides

814 total citations
16 papers, 620 citations indexed

About

Hareklea Markides is a scholar working on Genetics, Biomedical Engineering and Rheumatology. According to data from OpenAlex, Hareklea Markides has authored 16 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 7 papers in Biomedical Engineering and 5 papers in Rheumatology. Recurrent topics in Hareklea Markides's work include Mesenchymal stem cell research (7 papers), Osteoarthritis Treatment and Mechanisms (5 papers) and Bone Tissue Engineering Materials (4 papers). Hareklea Markides is often cited by papers focused on Mesenchymal stem cell research (7 papers), Osteoarthritis Treatment and Mechanisms (5 papers) and Bone Tissue Engineering Materials (4 papers). Hareklea Markides collaborates with scholars based in United Kingdom, Australia and Portugal. Hareklea Markides's co-authors include Alicia J. El Haj, Michael Rotherham, R.H. Morris, Oksana Kehoe, James E. Dixon, Ian Wimpenny, Chris Denning, Kevin M. Shakesheff, G E Morris and Jane S. McLaren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Hareklea Markides

16 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hareklea Markides United Kingdom 10 285 217 157 108 79 16 620
Michael Rotherham United Kingdom 13 443 1.6× 241 1.1× 268 1.7× 122 1.1× 92 1.2× 21 903
Kyung Sook Kim South Korea 18 357 1.3× 323 1.5× 215 1.4× 159 1.5× 57 0.7× 39 986
Eunna Chung United States 14 206 0.7× 177 0.8× 101 0.6× 119 1.1× 38 0.5× 16 480
Mathilde Hindié France 16 354 1.2× 218 1.0× 120 0.8× 155 1.4× 57 0.7× 27 731
Md. Muniruzzaman Japan 9 296 1.0× 333 1.5× 136 0.9× 134 1.2× 97 1.2× 12 669
Ekaterina A. Grebenik Russia 15 367 1.3× 209 1.0× 145 0.9× 161 1.5× 185 2.3× 27 820
Kristin M. Hennessy United States 10 531 1.9× 274 1.3× 219 1.4× 196 1.8× 78 1.0× 11 854
Gajadhar Bhakta Singapore 13 380 1.3× 207 1.0× 225 1.4× 153 1.4× 76 1.0× 14 742
Yafang Chen China 17 259 0.9× 273 1.3× 96 0.6× 106 1.0× 68 0.9× 55 676
Christine‐Maria Horejs United Kingdom 13 284 1.0× 202 0.9× 272 1.7× 113 1.0× 63 0.8× 38 811

Countries citing papers authored by Hareklea Markides

Since Specialization
Citations

This map shows the geographic impact of Hareklea Markides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hareklea Markides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hareklea Markides more than expected).

Fields of papers citing papers by Hareklea Markides

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hareklea Markides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hareklea Markides. The network helps show where Hareklea Markides may publish in the future.

Co-authorship network of co-authors of Hareklea Markides

This figure shows the co-authorship network connecting the top 25 collaborators of Hareklea Markides. A scholar is included among the top collaborators of Hareklea Markides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hareklea Markides. Hareklea Markides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Unnithan, Afeesh Rajan, Michael Rotherham, Hareklea Markides, & Alicia J. El Haj. (2023). Magnetic Ion Channel Activation (MICA)-Enabled Screening Assay: A Dynamic Platform for Remote Activation of Mechanosensitive Ion Channels. International Journal of Molecular Sciences. 24(4). 3364–3364. 2 indexed citations
2.
Markides, Hareklea, et al.. (2021). Experimental and mathematical modelling of magnetically labelled mesenchymal stromal cell delivery. Journal of The Royal Society Interface. 18(175). 20200558–20200558. 8 indexed citations
3.
Markides, Hareklea, Jane S. McLaren, Cameron Black, et al.. (2021). Short-Term Evaluation of Cellular Fate in an Ovine Bone Formation Model. Cells. 10(7). 1776–1776. 5 indexed citations
4.
Kaggie, Joshua, Hareklea Markides, Martin J. Graves, et al.. (2020). Ultra Short Echo Time MRI of Iron-Labelled Mesenchymal Stem Cells in an Ovine Osteochondral Defect Model. Scientific Reports. 10(1). 8451–8451. 8 indexed citations
5.
Markides, Hareklea, Heike Rudorf, James E. Dixon, et al.. (2019). Ex vivo MRI cell tracking of autologous mesenchymal stromal cells in an ovine osteochondral defect model. Stem Cell Research & Therapy. 10(1). 25–25. 37 indexed citations
6.
Markides, Hareklea, Jane S. McLaren, Neil D. Telling, et al.. (2018). Translation of remote control regenerative technologies for bone repair. npj Regenerative Medicine. 3(1). 9–9. 38 indexed citations
7.
Gonçalves, Ana I., Michael Rotherham, Hareklea Markides, et al.. (2018). Triggering the activation of Activin A type II receptor in human adipose stem cells towards tenogenic commitment using mechanomagnetic stimulation. Nanomedicine Nanotechnology Biology and Medicine. 14(4). 1149–1159. 33 indexed citations
8.
Chapman, Victoria, Hareklea Markides, Devi Rani Sagar, et al.. (2017). Therapeutic Benefit for Late, but Not Early, Passage Mesenchymal Stem Cells on Pain Behaviour in an Animal Model of Osteoarthritis. Stem Cells International. 2017. 1–11. 19 indexed citations
9.
Dixon, James E., G E Morris, Hareklea Markides, et al.. (2016). Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides. Proceedings of the National Academy of Sciences. 113(3). E291–9. 89 indexed citations
10.
Markides, Hareklea, et al.. (2016). The Application of Nanomagnetic Approaches for Targeting Adipose Derived Stem Cells for Use in Tendon Repair. Journal of Nanoscience and Nanotechnology. 16(9). 8989–8999. 2 indexed citations
11.
Harrison, Richard P., Hareklea Markides, R.H. Morris, et al.. (2016). Autonomous magnetic labelling of functional mesenchymal stem cells for improved traceability and spatial control in cell therapy applications. Journal of Tissue Engineering and Regenerative Medicine. 11(8). 2333–2348. 40 indexed citations
12.
Markides, Hareklea, Jane S. McLaren, & Alicia J. El Haj. (2015). Overcoming translational challenges – The delivery of mechanical stimuli in vivo. The International Journal of Biochemistry & Cell Biology. 69. 162–172. 15 indexed citations
13.
Sagar, Devi Rani, Hareklea Markides, James J. Burston, et al.. (2014). SAT0554 Intra-Articular Injection of Mesenchymal Stem Cells Improves Pain Behaviour in A Model of OA Pain. Annals of the Rheumatic Diseases. 73. 791–791. 2 indexed citations
14.
Markides, Hareklea, Oksana Kehoe, R.H. Morris, & Alicia J. El Haj. (2013). Whole body tracking of superparamagnetic iron oxide nanoparticle-labelled cells – a rheumatoid arthritis mouse model. Stem Cell Research & Therapy. 4(5). 126–126. 50 indexed citations
15.
Wimpenny, Ian, Hareklea Markides, & Alicia J. El Haj. (2012). Orthopaedic applications of nanoparticle-based stem cell therapies. Stem Cell Research & Therapy. 3(2). 13–13. 35 indexed citations
16.
Markides, Hareklea, Michael Rotherham, & Alicia J. El Haj. (2012). Biocompatibility and Toxicity of Magnetic Nanoparticles in Regenerative Medicine. Journal of Nanomaterials. 2012(1). 237 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026